Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 35, Issue 6, 2008, Pages 995-1001

  Kim, Seong Kyu ^a   Park, Sung Hoon ^a   Shin, I M Hee ^a   Choe, Jung Yoon ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

Alcohol consumption; Anti cyclic citrullinated peptide antibody; Extraarticular manifestation; Smoking

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHI SQUARE TEST; DISEASE DURATION; EXTRAARTICULAR MANIFESTATION; EYE INJURY; FEMALE; FISHER EXACT TEST; HUMAN; INFLAMMATION; KOREA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYELOGRAPHY; NEUROPATHY; PHYSICAL DISEASE BY BODY FUNCTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SJOEGREN SYNDROME; SMOKING; STUDENT T TEST; UNIVARIATE ANALYSIS; VASCULITIS;

ADULT; AGED; ALCOHOL DRINKING; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; MYELITIS; ODDS RATIO; PEPTIDES, CYCLIC; PREVALENCE; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; RHEUMATIC NODULE; SMOKING;

EID: 44949085650     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
2. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology Oxford 1999;38:668-74.
3. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-7.
4. Carmona L, Gonzalez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmarti R. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis 2003;62:897-900.
5. Cimmino MA, Salvarani C, Macchioni P, et al. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 2000;19:213-7.
6. Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2004;33:65-72.
7. Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med 1973;54:445-52.
8. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003;48:54-8.
9. Adebajo AO, Reid DM. The pattern of rheumatoid arthritis in West Africa and comparison with a cohort of British patients. Q J Med 1991;80:633-40.
10. Cohen MG, Li EK, Ng PY, Chan KL. Extra-articular manifestations are uncommon in southern Chinese with rheumatoid arthritis. Br J Rheumatol 1993;32:209-11.
11. Veerapen K, Mangat G, Watt I, Dieppe P. The expression of rheumatoid arthritis in Malaysian and British patients: a comparative study. Br J Rheumatol 1993;32:541-5.
12. Calguneri M, Ureten K, Akif Ozturk M, et al. Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol 2006;24:305-8.
13. Turesson C, Jacobsson L. Bergstrom U, Truedsson L, Sturfelt G. Predictors of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2000;29:358-64.
14. Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JM. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 1996;55:190-2.
15. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722-7.
16. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-9.
17. Perdriger A, Chales G, Semana G, et al. Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis. J Rheumatol 1997;24:1272-6.
18. Turesson C, Schaid DJ, Weyand CM, et al. The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 2005;7:R1386-93.
19. Vincent C, Nogueira L, Clavel C, Sebbag M, Serre G. Autoantibodies to citrullinated proteins: ACPA. Autoimmunity 2005;38:17-24.
20. Kroot EJ, de Jong BA, van Leeuwen MA, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:1831-5.
21. van Gaalen FA, van Aken J, Huizinga TW, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004;50:2113-21.
22. Ceccato F, Roverano S, Barrionuevo A, Rillo O, Paira S. The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Clin Rheumatol 2006;25:854-7.
23. Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Rönnelid J. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 2007;66:59-64.
24. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Linn-Rasker SP, van der Helin-van Mil AH, van Gaalen FA, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2006;65:366-71.
26. Jun JB, Kim TH, Kim DW, et al. The clinical characteristics of male patients with rheumatoid arthritis. J Korean Rheum Assoc 1996;3:1-10.
27. Conaghan PG, Green MJ, Emery P. Established rheumatoid arthritis. Baillieres Best Pract Res Clin Rheumatol 1999;13:561-75.
28. Quinn MA, Gough AK, Green MJ, et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology Oxford 2006;45:478-80.
29. del Val del Arno N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clin Exp Rheumatol 2006;24:281-6.
30. Stolt P, Bengtsson C, Nordmark B, et al. EIRA Study Group. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-41.
31. Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006;119:503.
32. Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 2005;23:861-6.
33. Manfredsdottir VF, Vikingsdottir T, Jonsson T, et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology Oxford 2006;45:734-40.
34. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 2000;27:630-7.
35. Finckh A, Dehler S, Costenbader KH, Gabay C; Swiss Clinical Quality Management Project for RA. Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2007;66:1066-71.
36. Harrison BJ, Silman AJ, Wiles NJ, Scott DG, Symmons DP. The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum 2001;44:323-30.
37. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
38. Lee HS, Irigoyen P, Kern M, et al. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum 2007;56:1745-53.
39. Bengtsson AA, Rylander L, Hagmar L, Nived O, Sturfelt G. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology Oxford 2002;41:563-71.
40. Lyu LC, Hsu CY, Yeh CY, Lee MS, Huang SH, Chen CL. A case-control study of the association of diet and obesity with gout in Taiwan. Am J Clin Nutr 2003;78:690-701.
41. Voigt LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology 1994;5:525-32.
42. Cerhan JR, Saag KG, Criswell LA, Merlino LA, Mikuls TR. Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women. J Rheumatol 2002;29:246-54.
43. Jonsson IM, Verdrengh M, Brisslert M, et al. Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci USA 2007;104:258-63.
44. Kallberg H, Padyukov L, Ronnelid J, Klareskog L, Alfredsson L. Ethanol consumption is associated with decreased risks for developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2007;66 Suppl:92.